Cingulate Inc (CING)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $62.53M
Last updated: Nov 17, 2026 at 4:42 PM ET
Cingulate Inc (CING) Statistics
Cingulate (CING) has a market cap of $62.53M and an enterprise value of $42.72M. Its share count is up 167.84% from a year earlier. Revenue fell 100.00% over the last 12 months from the 12 months before.
Total Valuation
Enterprise value is 31.69% below the market cap, as cash exceeds debt.
| Market Cap | $62.53M |
|---|---|
| Enterprise Value | $42.72M |
| Latest price (Nov 17, 2026) | $4.72 |
Key Dates
| Last Earnings Date | Nov 13, 2026 |
|---|---|
| Fiscal Year End | December |
Price Statistics
The stock is up 35.24% over 52 weeks and trades 2.07% below its 50-day average.
| Beta (1Y) | 1.24 |
|---|---|
| 52-Week Change | +35.24% |
| 1-Month Change | +8.26% |
| 3-Month Change | -10.44% |
| 6-Month Change | +7.52% |
| Total Return (1Y) | +35.24% |
| Total Return (3Y CAGR) | -59.67% |
| Return vs SPY (1Y) | +28.09% |
| Max Drawdown (1Y) | -69.13% |
| Max Drawdown (3Y) | -98.43% |
| Sharpe Ratio (1Y) | 0.37 |
| Correlation with SPY (1Y) | 0.19 |
| 50-Day Average | $4.82 |
| 200-Day Average | $5.37 |
| 52-Week Range | $3.16 to $11.89 |
| RSI (14 Days) | 51.3 |
| Average Volume (20 Days) | 226.89K |
Financial Position
Current assets cover 3.90x current liabilities, and total debt is 0.16x shareholder equity.
| Current Ratio | 3.90x |
|---|---|
| Quick Ratio | 3.90x |
| Debt / Equity | 0.16x |
Returns and Efficiency
| Return on Capital Employed (ROCE) | -127.62% |
|---|---|
| ROIC (5Y Average) | 182.57% |
Scores
CING has a Piotroski F-Score of 2 of 9, in the weak band of 0 to 2.
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Piotroski F-Score | 2 of 9 |
|---|---|
| Piotroski Strength | Weak |
Income Statement
Revenue was $0 over the last 12 months.
| Revenue | $0 |
|---|---|
| Revenue Growth (YoY) | -100.00% |
| Gross Profit | $419.06K |
| Operating Income | -$26.42M |
| Pretax Income | -$29.19M |
| Net Income | -$29.19M |
| EBIT | -$27.65M |
| Reported EPS (TTM) | -$2.77 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 73.78% of the $28.15M in total assets.
| Cash and Equivalents | $23.19M |
|---|---|
| Total Debt | $3.37M |
| Net Cash | $19.81M |
| Net Cash Per Share | $1.36 |
| Working Capital | $18.83M |
| Shareholder Equity | $20.77M |
| Book Value Per Share | $1.43 |
| Total Assets | $28.15M |
| Total Liabilities | $7.38M |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $367.66K of capital spending, operating cash flow left -$24.16M of free cash flow.
| Operating Cash Flow | -$23.79M |
|---|---|
| Capital Expenditures | $367.66K |
| Free Cash Flow | -$24.16M |
| FCF Per Share | -$1.66 |
| Depreciation and Amortization | $393.54K |
Trailing 12 months through Sep 30, 2026.
Stock Splits
The last split was a 1-for-12 reverse split on Aug 9, 2024.
| Last Split Date | Aug 9, 2024 |
|---|---|
| Split Type | Reverse split |
| Split Ratio | 1:12 |
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About CING
What is CING's market cap?
Cingulate has a market cap of $62.53M. Its enterprise value, which adds debt and subtracts cash, is $42.72M.
How many shares of CING are outstanding?
Cingulate has 14.55M shares outstanding. The count is up 167.84% from a year earlier.
Does CING pay a dividend?
No. Cingulate does not pay a dividend.
How much debt does CING have?
Cingulate has $3.37M of total debt and $23.19M of cash and equivalents, a net cash position of $19.81M.
CING pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors